LIMAA Technologies, an innovative deep-tech startup in the field of medical technology solutions, is proud to announce a strategic partnership with Labor Becker, one of Germany’s largest and owner-managed diagnostic laboratories. The collaboration is set to accelerate the development of LIMAA's end-to-end histopathology platform, enhancing scalability and precision in .

LIMAA Technologies是医疗技术解决方案领域的一家创新性深度技术初创公司，它很自豪地宣布与德国最大且由所有者管理的诊断实验室之一Labor Becker建立战略合作伙伴关系。此次合作旨在加速LIMAA端到端组织病理学平台的开发，增强中的可扩展性和准确性。

tissue diagnostics

组织诊断学

, including integrated

，包括集成

genomics

基因组学

.

.

By combining LIMAA's cutting-edge histopathology technology with Labor Becker's extensive laboratory activities, the partnership will streamline diagnostic workflows, reduce turnaround times, and significantly improve patient outcomes by delivering more accurate and comprehensive results. The development will allow healthcare providers to better generate, manage and analyze histopathology data on a large scale..

通过将LIMAA的尖端组织病理学技术与Labor Becker的广泛实验室活动相结合，该合作关系将简化诊断工作流程，减少周转时间，并通过提供更准确和全面的结果显着改善患者预后。这一发展将使医疗保健提供者能够更好地大规模生成、管理和分析组织病理学数据。。

CEO of LIMAA Technologies, Dr. Fabian Mohr, emphasized the importance of this collaboration: 'Partnering with Labor Becker marks a significant milestone in our mission to democratize access to advanced tissue diagnostics. Our scalable histopathology platform is designed to empower pathologists with faster, more precise tools while driving greater efficiency across labs of all sizes.

利马科技公司首席执行官费边·莫尔博士强调了这一合作的重要性：“与工党贝克尔的合作标志着我们实现先进组织诊断民主化的重要里程碑。我们可扩展的组织病理学平台旨在为病理学家提供更快，更精确的工具，同时提高各种规模实验室的效率。

Together with Labor Becker, we are taking a pivotal step towards transforming the future of diagnostics and patient care.”.

与工党贝克尔一起，我们正在朝着改变诊断和患者护理的未来迈出关键的一步。”。

LIMAA's histopathology platform offers a fully integrated digital workflow encompassing sample preparation, AI-powered image analysis, and cloud-based reporting. With scalability at its core, the platform is designed to accommodate the needs of both smaller clinics and large laboratory networks.

LIMAA的组织病理学平台提供了一个完全集成的数字工作流程，包括样品制备，人工智能图像分析和基于云的报告。该平台以可扩展性为核心，旨在满足小型诊所和大型实验室网络的需求。

CEO of Labor Becker, Dr. Marc Becker, also shared excitement for the collaboration: 'At Labor Becker, we continually strive to enhance the efficiency and accuracy of our diagnostics, and this partnership with LIMAA is an ideal match. Their histopathology platform enables us to offer cutting-edge diagnostics, streamline operations, and reduce turnaround times, all while maintaining top-quality pathology services.

工党贝克尔公司首席执行官马克·贝克尔博士也对此次合作感到兴奋：“在工党贝克尔公司，我们不断努力提高诊断的效率和准确性，与利马的合作是一场理想的比赛。他们的组织病理学平台使我们能够提供尖端诊断，简化操作并减少周转时间，同时保持高质量的病理学服务。

We're excited to push the boundaries of what's possible in histopathology together.'.

我们很高兴能够将组织病理学的可能界限推向一起。”。

https://www.bionity.com/en/news/1185418/limaa-technologies-and-labor-becker-announce-strategic-partnership.html

https://www.bionity.com/en/news/1185418/limaa-technologies-and-labor-becker-announce-strategic-partnership.html

Precise diagnostics with artificial intelligence

人工智能精确诊断

BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off

波黑数字健康加速器指导Aignostics GmbH进行分拆

Read news

阅读新闻

Most read news

阅读最多的新闻

1

1

Groundbreaking technology can turn cancer cells back into normal cells

开创性的技术可以使癌细胞恢复正常细胞

2

2

Insight into schizophrenia disease mechanisms found in the eye

深入了解眼睛中发现的精神分裂症疾病机制

3

3

Microbe of the Year 2023: Bacillus subtilis – for health and technology

2023年的微生物：枯草芽孢杆菌-用于健康和技术

4

4

Electric fungi: The biobattery that needs to be fed

电真菌：需要喂养的生物电池

5

5

Tuberculosis research: promising new active agent

结核病研究：有前途的新型活性剂

Topics

主题

histopathology

组织病理学

tissue diagnostics

组织诊断学

cancer diagnostics

癌症诊断

genomics

基因组学

diagnostics

诊断

Show all

全部显示

Show less

显示更少

Organizations

组织

LIMAA Technologies

LIMAA 技术

Labor Becker MVZ

劳工贝克尔MVZ